Attached files

file filename
EX-10.17 - LEASE AGREEMENT BETWEEN FULLERTON BUSINESS CENTER, LLC, LESSOR, AND ALLIED MED, INC., LESSEE, DATED JULY 8, 2009 (UNIT H) - AMEXDRUG CORPamexdrug10qexh1017.pdf
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORPamexdrug10qexh312.txt
EX-32.2 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORPamexdrug10qexh322.txt
EX-10.18 - GUARANTY OF LEASE BY JACK AMIN (UNIT H) - AMEXDRUG CORPamexdrug10qexh1018.txt
10-Q - AMEXDRUG CORPORATION FORM 10-Q SEPTEMBER 30, 2009 - AMEXDRUG CORPamexdrug10q.txt
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORPamexdrug10qexh321.txt
EX-10.17 - LEASE AGREEMENT BETWEEN FULLERTON BUSINESS CENTER, LLC, LESSOR, AND ALLIED MED, INC., LESSEE, DATED JULY 8, 2009 (UNIT H) - AMEXDRUG CORPamexdrug10qexh1017.txt

================================================================================


                                  EXHIBIT 31.1

                                  SECTION 302
                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Jack Amin, certify that:

1.       I have reviewed this quarterly report on Form 10-Q of Amexdrug
         Corporation,

2.       Based on my knowledge, this quarterly report does not contain any
         untrue statement of a material fact or omit to state a material fact
         necessary to make the statements made, in light of the circumstances
         under which such statements were made, not misleading with respect to
         the period covered by this quarterly report;

3.       Based on my knowledge, the financial statements, and other financial
         information included in this quarterly report, fairly present in all
         material respects the financial condition, the results of operations
         and cash flows of the registrant as of, and for, the periods presented
         in this quarterly report;

4.       The registrant's other certifying officer(s) and I are responsible for
         establishing and maintaining disclosure controls and procedures (as
         defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
         control over financial reporting (as defined in Exchange Act Rules
         13a-15(f) and 15d-15(f)) for the registrant and we have:

         (a)      designed such disclosure controls and procedures, or caused
                  such disclosure controls and procedures to be designed under
                  our supervision, to ensure that material information relating
                  to the registrant, including its consolidated subsidiaries, is
                  made known to us by others within those entities, particularly
                  during the period in which this quarterly report is being
                  prepared;

         (b)      designed such internal control over financial reporting or
                  caused such internal control over financial reporting to be
                  designed under our supervision, to provide reasonable
                  assurance regarding the reliability of financial reporting and
                  the preparation of financial statements for external purposes
                  in accordance with generally accepted accounting principles;

         (c)      evaluated the effectiveness of the registrant's disclosure
                  controls and procedures and presented in this quarterly report
                  our conclusions about the effectiveness of the disclosure
                  controls and procedures, as of the end of the period covered
                  by this quarterly report based on such evaluation; and

         (d)      disclosed in this quarterly report any change in the
                  registrant's internal control over financial reporting that
                  occurred during the registrant's most recent fiscal quarter
                  that has materially affected, or is reasonably likely to
                  materially affect, the registrant's internal control over
                  financial reporting; and

5.       The registrant's other certifying officer(s) and I have disclosed,
         based on our most recent evaluation of internal control over financial
         reporting, to the registrant's auditors and the audit committee of the
         registrant's board of directors (or persons performing the equivalent
         functions):

         (a)      all significant deficiencies in the design or operation of
                  internal control over financial reporting which are reasonably
                  likely to adversely affect the registrant's ability to record,
                  process, summarize and report financial information; and

         (b)      any fraud, whether or not material, that involves management
                  or other employees who have a significant role in the
                  registrant's internal control over financial reporting.

Date:  November 10, 2009                  /s/ Jack Amin
                                          ----------------------------------
                                          Jack Amin, Chief Executive Officer





-------------------------------------------------------------------------------